It has been estimated that up to 75% of patients with small HCC and 20% of patients with large HCC may have normal serum AFP level that could escape from HCC surveillance [37, 38]; however, several investigators concluded that AFP fails as a reliable marker, mainly because it shows poor sensitivity and specificity [7, 39]. The gene discussed is AFP; the disease is hepatocellular carcinoma.